Detalhe da pesquisa
1.
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Liver Transpl
; 15(9): 1133-41, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19718643
2.
Immunomodulatory therapy for Crohn's disease resulting in acute liver failure.
Inflamm Bowel Dis
; 10(6): 894-5, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15626912
3.
Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.
Hepatology
; 38(6): 1378-83, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14647048
4.
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Hepatology
; 37(2): 378-84, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12540788
5.
Hepatitis C virus kinetics during and immediately after liver transplantation.
Hepatology
; 35(3): 680-7, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11870384
6.
Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
J Hepatol
; 36(3): 356-61, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11867179
7.
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.
Hepatology
; 35(1): 132-9, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11786969
8.
TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.
Hepatology
; 35(2): 385-92, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11826413
9.
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Hepatology
; 36(6): 1367-73, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12447861